SEARCH

SEARCH BY CITATION

References

  • 1
    Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage and age. J Natl Cancer Inst 2008; 100: 11847.
  • 2
    Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Beruccio P, Negri E, La Vecchia C. Trends in oesophageal cancer incidence and mortality. Eur Int J Cancer 2008; 122: 111829.
  • 3
    Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 1426.
  • 4
    Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex and histologic type, 1977–2005. Br J Cancer 2009; 101: 8559.
  • 5
    Post PN, Siersema, P.D., van Dekken, H. Rising incidence of clinically evident Barrett's esophagus in the Netherlands: a nation-wide registry of pathology reports. Scan J Gastroenterol 2007; 42: 1722.
  • 6
    Coleman HG, Bhat S, Murray LJ, McManus D, Gavin AT, Johnston BT. Increasing incidence of Barrett's oesophagus: a population-based study. Eur J Epidemiol 2011; 26(9): 73945.
  • 7
    Berrino F, International agency for research on cancer and commission of the European communities survival of cancer patients in Europe: the EUROCARE-2 study International Agency for Research on Cancer, 1999.
  • 8
    Mitry E, Rachet B, Quinn MJ, Cooper N, Coleman MP. Survival for cancer of the oesophagus in England and Wales up to 2001. Br J Cancer 2008; 99: 13.
  • 9
    Navarro Silvera A, Rohan TE. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control 2007; 18: 727.
  • 10
    Aggett PJ. Trace elements in human nutrition. J Trop Pediatr 1980; 26: 435.
  • 11
    He K. Trace elements in nails as biomarkers in clinical research. Eur J Clin Invest 2011; 41: 98102.
  • 12
    Garland M, Morris SJ, Rosner BA, Stampfer MJ, Spate VL, Baskett CJ, Willett WC, Hunter DJ. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomark Prev 1993; 2: 4937.
  • 13
    Slotnick MJ, Nriagu JO. Validity of human nails as a biomarker of arsenic and selenium exposure: a review. Environ Res 2006; 102: 12539.
  • 14
    Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 2005; 64: 52742.
  • 15
    Schrauzer GN. Selenium and selenium-antagonistic elements in nutritional cancer prevention. Crit Rev Biotechnol 2009; 29: 1017.
  • 16
    Steevens J, van den Brandt PA, Goldbohm RA, Schouten LJ. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenterology 2009; 138: 170413.
  • 17
    Steevens J, Schouten LJ, Driessen ALC, Huysentruyt CJR, Keulemans YCA, Goldbohm A, van den Brandt PA. Toenail selenium status and the risk of Barrett's esophagus: the Netherlands Cohort Study. Cancer Causes Control 2010; 21: 225968.
  • 18
    Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 2004; 15: 5728.
  • 19
    Prasad AS. Zinc and gene expression. In: Prasad AS ed. Biochemistry of zinc. New York: Plenum Press, 1993. 5576.
  • 20
    Food and Agriculture Organisation of the United Nations & World Health Organisation (FAO/WHO), Human vitamin & mineral requirements: report of a joint FAO/WHO expert consultation Food & Nutrition Division Food and Agriculture Organisation of the United Nations, 2001.
  • 21
    Celardo I, Pedersen JZ, Traversa E, Ghibelli L. Pharmacological potential of cerium oxide nanoparticles. Nanoscale 2011; 3: 141120.
  • 22
    Palizban AA, Sadeghi-Aliabadi H, Abdollahpour F. Effect of cerium lanthanide on Hela and MCF-7 cancer cell growth in the presence of transferrin. Res Pharm Sci 2010; 5: 11925.
  • 23
    Agency for Toxic Substances Disease Registry (ATSDR), Toxicological profile for Chromium US Department of Health and Human Services, Public Health Service, 2008.
  • 24
    Gatto NM, Kelsh MA, Mai DH, Suh M, Proctor DM. Occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract: a meta-analysis. Cancer Epidemiol 2010; 34: 38899.
  • 25
    Agency for Toxic Substances Disease Registry (ATSDR), Toxicological profile for Mercury US Department of Health & Social Services, Public Health Service, 1999.
  • 26
    Anderson LA, Johnston BT, Watson PR, Murphy SJ, Ferguson HR, Comber H, McGuigan J, Reynolds JV, Murray LJ. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res 2006; 66: 497582.
  • 27
    Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A, Wareham N. EPIC Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999; 80: 95103.
  • 28
    Küppers G, Erdtmann G. Trace element determination in high-purity scandium by neutron activation analysis and pre-irradiation matrix separation. J Radioanal Nucl Chem 1995; 189: 18390.
  • 29
    O'Doherty MG, Abnet CC, Murray LJ, Woodside JV, Anderson LA, Brockman JD, Cantwell MM. Iron intake and markers of iron status and risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Causes Control 2010; 21: 226979.
  • 30
    Fleckman P. Basic science of the nail unit. In: Scher RK, Daniel, C.R. eds. Nails: therapy, diagnosis, surgery. Philadelphia: Saunders, 1997. 3754.
  • 31
    Hunter DJ, Morris JS, Chute CG, Kushner GA, Colditz MJ, Stampfer FE, Speizer FE, Willett WC. Predictors of selenium concentration in human toenails. Am J Epidemiol 1990; 132: 11422.
  • 32
    Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, Bernstein L, Hartge P. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Persp 2004; 112: 16916.
  • 33
    Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 13739.
  • 34
    Combs GF, Jr., Lu J. Selenium as a cancer preventive agent. In: Hatfield DL, Berry MJ, Gladyshev VN, eds. Selenium, 2nd edn. New York: Springer, 2006. 24964.
  • 35
    Kardinaal AFM, Kok FJ, Kohlmeier L, Martin-Moreno JM, Ringstad J, Gomez-Aracena J, Mazaev VP, Thamm M, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, et al. Association between toenail selenium and risk of acute myocardial infarction in European men, the EURAMIC study. Am J Epidemiol 1997; 145: 3739.
  • 36
    Rudolph RE, Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ. Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's oesophagus. J Natl Cancer Inst 2003; 95: 7507.
  • 37
    Martin-Moreno JM, Gorgojo L, Riemersma RA, Gomez-Aracena J, Kark JD, Guillen J, Jimenez J, Ringstad JJ, Fernandez-Crehuet J, Bode P, Kok FJ. For the heavy metals and Myocardial Infarction Study Group. Myocardial infarction risk in relation to zinc concentration in toenails. Brit J Nutr 2003; 89: 6738.
  • 38
    Gonzalez A, Peters U, Lampe JW, Satia JA, Whitea E. Correlates of toenail zinc in a free-living US population. Ann Epidemiol 2008; 18: 747.
  • 39
    Costello LC, Franklin RB, Tan M, Bagasra O. Zinc and prostate cancer: a critical scientific, medical and public interest issue (United States). Cancer Causes Control 2005; 16: 90115.
  • 40
    Zaichick V, Sviridova TV, Zaichick SV. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 1997; 29: 56574.
  • 41
    World Cancer Research Fund/American Institute for Cancer Research, Food, nutrition, physical activity and the prevention of cancer: a global perspective. AICR, 2007.
  • 42
    Murphy SJ, Anderson LA, Ferguson HR, Johnston BT, Watson PR, McGuigan J, Comber H, Reynolds JV, Murray LJ, Cantwell MM. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus. J Nutr 2010; 140: 175763.
  • 43
    Abnet CC, Lai B, Qiao YL, Vogt S, Luo X-M, Taylor PR, Dong Z-W, Mark SD, Dawsey SM. Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst 2005; 97: 3016.
  • 44
    Wong PF, Abubakar S. Comparative transcriptional study of the effects of high intracellular zinc on prostate carcinoma cells. Oncol Rep 2010; 23: 150116.
  • 45
    Cousins RJ. A role of zinc in the regulation of gene expression. Proc Nutr Soc 1998; 57: 30711.
  • 46
    Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 4617.
  • 47
    Mezei G, Kheifets L. Selection bias and its implications for case-control studies: a case study of magnetic field exposure and childhood leukaemia. Int J Epidemiol 2006; 35: 397406.
  • 48
    Northern Ireland Statistics and Research Agency. Northern Ireland health and social well-being survey Belfast, 2001.
  • 49
    Allen NE, Morris JS, Ngwenyama RA, Key TJ. A case-control study of selenium in nails and prostate cancer risk in British men. Br J Cancer 2004; 90: 13926.
  • 50
    Cabral HJ. Multiple comparisons procedures. Circulation 2008; 117: 698701.